Teduglutide in Short Bowel Syndrome Patients

Medical University of Vienna

Status: Completed

Conditions: Short Bowel Syndrome

Treatments: Drug: Teduglutide

Study type: Observational

Funder types: Other

Identifiers

NCT04857801

131290

Details and patient eligibility

About

A retrospective analysis was performed using data of patients suffering from non-malignant SBS-IF. They were treated with teduglutide in a multidisciplinary SBS-IF program at a single university medical center between June 2016 and June 2020.

Enrollment: 17 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• SBS-IF

Exclusion criteria

• < 18 years
• Incompliance
• < 6 months of treatment